ReP USP - Resultado da busca

Trabalho de evento-resumo periodico
Predicting dosimetry for therapy using imaging analogs of therapeutic radiopharmaceuticals: An uncertainty and sensitivity analysis applicable to Theranostics (2015)
Josefsson, Anders; Hobbs, Robert; Plyku, Donika; Huang, Kevin; Willegaignon, Jose; Coura Filho, George; Duarte, Paulo; Sapienza, Marcelo; Sgouro, George
Fonte: Journal of Nuclear Medicine. Unidade: FM
Assuntos: RADIOTERAPIA, RADIOTRAÇADORES, DESNSITOMETRIA ÓSSEA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
JOSEFSSON, Anders et al. Predicting dosimetry for therapy using imaging analogs of therapeutic radiopharmaceuticals: An uncertainty and sensitivity analysis applicable to Theranostics. Journal of Nuclear Medicine. New York: Faculdade de Medicina, Universidade de São Paulo. Disponível em: http://jnm.snmjournals.org/content/56/supplement_3/1023.abstract?sid=6531a440-e635-4a18-8cc0-0dce6f5316d9. Acesso em: 02 nov. 2025. , 2015
APA
Josefsson, A., Hobbs, R., Plyku, D., Huang, K., Willegaignon, J., Coura Filho, G., et al. (2015). Predicting dosimetry for therapy using imaging analogs of therapeutic radiopharmaceuticals: An uncertainty and sensitivity analysis applicable to Theranostics. Journal of Nuclear Medicine. New York: Faculdade de Medicina, Universidade de São Paulo. Recuperado de http://jnm.snmjournals.org/content/56/supplement_3/1023.abstract?sid=6531a440-e635-4a18-8cc0-0dce6f5316d9
NLM
Josefsson A, Hobbs R, Plyku D, Huang K, Willegaignon J, Coura Filho G, Duarte P, Sapienza M, Sgouro G. Predicting dosimetry for therapy using imaging analogs of therapeutic radiopharmaceuticals: An uncertainty and sensitivity analysis applicable to Theranostics [Internet]. Journal of Nuclear Medicine. 2015 ; 56( suppl. 3):[citado 2025 nov. 02 ] Available from: http://jnm.snmjournals.org/content/56/supplement_3/1023.abstract?sid=6531a440-e635-4a18-8cc0-0dce6f5316d9
Vancouver
Josefsson A, Hobbs R, Plyku D, Huang K, Willegaignon J, Coura Filho G, Duarte P, Sapienza M, Sgouro G. Predicting dosimetry for therapy using imaging analogs of therapeutic radiopharmaceuticals: An uncertainty and sensitivity analysis applicable to Theranostics [Internet]. Journal of Nuclear Medicine. 2015 ; 56( suppl. 3):[citado 2025 nov. 02 ] Available from: http://jnm.snmjournals.org/content/56/supplement_3/1023.abstract?sid=6531a440-e635-4a18-8cc0-0dce6f5316d9
Artigo de periodico
Radioiodine Therapy for Graves Disease: Thyroid Absorbed Dose of 300 Gy—Tuning the Target for Therapy Planning (2013)
Willegaignon, José S; Sapienza, Marcelo; Buchpiguel, Carlos
Fonte: Clinical Nuclear Medicine. Unidade: FM
Assuntos: DOENÇA DE GRAVES (CINTILOGRAFIA;DIAGNÓSTICO), SEGUIMENTOS, RADIOMETRIA, RADIOIMUNOENSAIO (USO TERAPÊUTICO), DOSIMETRIA, HIPERTIREOIDISMO (USO TERAPÊUTICO)
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
WILLEGAIGNON, José S e SAPIENZA, Marcelo e BUCHPIGUEL, Carlos. Radioiodine Therapy for Graves Disease: Thyroid Absorbed Dose of 300 Gy—Tuning the Target for Therapy Planning. Clinical Nuclear Medicine, v. 38, n. 4, p. 231-236, 2013Tradução . . Disponível em: https://doi.org/10.1097/RLU.0b013e3182816717. Acesso em: 02 nov. 2025.
APA
Willegaignon, J. S., Sapienza, M., & Buchpiguel, C. (2013). Radioiodine Therapy for Graves Disease: Thyroid Absorbed Dose of 300 Gy—Tuning the Target for Therapy Planning. Clinical Nuclear Medicine, 38( 4), 231-236. doi:10.1097/RLU.0b013e3182816717
NLM
Willegaignon JS, Sapienza M, Buchpiguel C. Radioiodine Therapy for Graves Disease: Thyroid Absorbed Dose of 300 Gy—Tuning the Target for Therapy Planning [Internet]. Clinical Nuclear Medicine. 2013 ; 38( 4): 231-236.[citado 2025 nov. 02 ] Available from: https://doi.org/10.1097/RLU.0b013e3182816717
Vancouver
Willegaignon JS, Sapienza M, Buchpiguel C. Radioiodine Therapy for Graves Disease: Thyroid Absorbed Dose of 300 Gy—Tuning the Target for Therapy Planning [Internet]. Clinical Nuclear Medicine. 2013 ; 38( 4): 231-236.[citado 2025 nov. 02 ] Available from: https://doi.org/10.1097/RLU.0b013e3182816717
Artigo de periodico
Outpatient Radioiodine Therapy for Thyroid Cancer: A Safe Nuclear Medicine Procedure (2011)
Willegaignon, José; Sapienza, Marcelo; Ono, Carla; Watanabe, Tomoco; Guimaraes, Maria Ines; Gutterres, Ricardo; Marechal, Maria Helena; Buchpiguel, Carlos
Fonte: Clinical Nuclear Medicine. Unidade: FM
Assuntos: NEOPLASIAS DA TIREOIDE (PATOLOGIA), NEOPLASIAS DA TIREOIDE (EFEITOS ADVERSOS), IODO, RADIOIMUNOENSAIO (ADMINISTRAÇÃO E DOSAGEM)
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
WILLEGAIGNON, José et al. Outpatient Radioiodine Therapy for Thyroid Cancer: A Safe Nuclear Medicine Procedure. Clinical Nuclear Medicine, v. 36, n. 6, p. 440-445, 2011Tradução . . Disponível em: https://doi.org/10.1097/RLU.0b013e3182184fa0. Acesso em: 02 nov. 2025.
APA
Willegaignon, J., Sapienza, M., Ono, C., Watanabe, T., Guimaraes, M. I., Gutterres, R., et al. (2011). Outpatient Radioiodine Therapy for Thyroid Cancer: A Safe Nuclear Medicine Procedure. Clinical Nuclear Medicine, 36( 6), 440-445. doi:10.1097/RLU.0b013e3182184fa0
NLM
Willegaignon J, Sapienza M, Ono C, Watanabe T, Guimaraes MI, Gutterres R, Marechal MH, Buchpiguel C. Outpatient Radioiodine Therapy for Thyroid Cancer: A Safe Nuclear Medicine Procedure [Internet]. Clinical Nuclear Medicine. 2011 ; 36( 6): 440-445.[citado 2025 nov. 02 ] Available from: https://doi.org/10.1097/RLU.0b013e3182184fa0
Vancouver
Willegaignon J, Sapienza M, Ono C, Watanabe T, Guimaraes MI, Gutterres R, Marechal MH, Buchpiguel C. Outpatient Radioiodine Therapy for Thyroid Cancer: A Safe Nuclear Medicine Procedure [Internet]. Clinical Nuclear Medicine. 2011 ; 36( 6): 440-445.[citado 2025 nov. 02 ] Available from: https://doi.org/10.1097/RLU.0b013e3182184fa0
Artigo de periodico
Is it necessary to reduce the radioiodine dose in patients with thyroid cancer and renal failure? (2010)
Willegaignon, José; Ribeiro, Verena Pinto Brito; Sapienza, Marcelo; Ono, Carla; Watanabe, Tomoco; Buchpiguel, Carlos
Fonte: Arquivos Brasileiros de Endocrinologia e Metabologia. Unidade: FM
Assuntos: INSUFICIÊNCIA CARDÍACA, NEOPLASIAS DA TIREOIDE, RADIOIMUNOENSAIO, CARCINOMA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
WILLEGAIGNON, José et al. Is it necessary to reduce the radioiodine dose in patients with thyroid cancer and renal failure?. Arquivos Brasileiros de Endocrinologia e Metabologia, v. 54, n. 4, p. 413-418, 2010Tradução . . Disponível em: https://doi.org/10.1590/S0004-27302010000400011. Acesso em: 02 nov. 2025.
APA
Willegaignon, J., Ribeiro, V. P. B., Sapienza, M., Ono, C., Watanabe, T., & Buchpiguel, C. (2010). Is it necessary to reduce the radioiodine dose in patients with thyroid cancer and renal failure? Arquivos Brasileiros de Endocrinologia e Metabologia, 54( 4), 413-418. doi:10.1590/S0004-27302010000400011
NLM
Willegaignon J, Ribeiro VPB, Sapienza M, Ono C, Watanabe T, Buchpiguel C. Is it necessary to reduce the radioiodine dose in patients with thyroid cancer and renal failure? [Internet]. Arquivos Brasileiros de Endocrinologia e Metabologia. 2010 ; 54( 4): 413-418.[citado 2025 nov. 02 ] Available from: https://doi.org/10.1590/S0004-27302010000400011
Vancouver
Willegaignon J, Ribeiro VPB, Sapienza M, Ono C, Watanabe T, Buchpiguel C. Is it necessary to reduce the radioiodine dose in patients with thyroid cancer and renal failure? [Internet]. Arquivos Brasileiros de Endocrinologia e Metabologia. 2010 ; 54( 4): 413-418.[citado 2025 nov. 02 ] Available from: https://doi.org/10.1590/S0004-27302010000400011
Artigo de periodico
Could the treatment of differentiated thyroid carcinoma with 3.7 and 5.55 GBq of (131I)NaI, on an outpatient basis, be safe? (2009)
Carvalho, José Willegaignon de Amorim de; Sapienza, Marcelo; Ono, Carla; Watanabe, Tomoco; Guimarães, Maria Inês; Gutterres, Ricardo; Marechal, Maria Helena; Buchpiguel, Carlos
Fonte: Nuclear Medicine Communications. Unidade: FM
Assuntos: NEOPLASIAS DA TIREOIDE (TERAPIA), CARCINOMA, SEGUIMENTOS, DOSIMETRIA LUMINESCENTE, RADIOISÓTOPOS (APLICAÇÕES TERAPÊUTICAS), EXPOSIÇÃO AMBIENTAL
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CARVALHO, José Willegaignon de Amorim de et al. Could the treatment of differentiated thyroid carcinoma with 3.7 and 5.55 GBq of (131I)NaI, on an outpatient basis, be safe?. Nuclear Medicine Communications, n. 7, p. 533-541, 2009Tradução . . Disponível em: https://doi.org/10.1097/mnm.0b013e32832b79bc. Acesso em: 02 nov. 2025.
APA
Carvalho, J. W. de A. de, Sapienza, M., Ono, C., Watanabe, T., Guimarães, M. I., Gutterres, R., et al. (2009). Could the treatment of differentiated thyroid carcinoma with 3.7 and 5.55 GBq of (131I)NaI, on an outpatient basis, be safe? Nuclear Medicine Communications, ( 7), 533-541. doi:10.1097/mnm.0b013e32832b79bc
NLM
Carvalho JW de A de, Sapienza M, Ono C, Watanabe T, Guimarães MI, Gutterres R, Marechal MH, Buchpiguel C. Could the treatment of differentiated thyroid carcinoma with 3.7 and 5.55 GBq of (131I)NaI, on an outpatient basis, be safe? [Internet]. Nuclear Medicine Communications. 2009 ;( 7): 533-541.[citado 2025 nov. 02 ] Available from: https://doi.org/10.1097/mnm.0b013e32832b79bc
Vancouver
Carvalho JW de A de, Sapienza M, Ono C, Watanabe T, Guimarães MI, Gutterres R, Marechal MH, Buchpiguel C. Could the treatment of differentiated thyroid carcinoma with 3.7 and 5.55 GBq of (131I)NaI, on an outpatient basis, be safe? [Internet]. Nuclear Medicine Communications. 2009 ;( 7): 533-541.[citado 2025 nov. 02 ] Available from: https://doi.org/10.1097/mnm.0b013e32832b79bc
Trabalho de evento-resumo periodico
Evaluation of the potential absorbed doses from patients based on whole-body I-131 clearance in thyroid cancer therapy (2006)
Carvalho, Jose W.; Guimarães, Maria Ines C.; Stabin, Michael G.; Malvestiti, Luiz F.; Sapienza, Marcelo; Sordi, Gian Maria A. A.; Marone, Marilia S.; Buchpiguel, Carlos Alberto
Fonte: World Journal of Nuclear Medicine. Nome do evento: Congress of World Federation of Nuclear Medicine & Biology. Unidade: FM
Assuntos: NEOPLASIAS DA TIREOIDE, RADIOATIVIDADE ARTIFICIAL, FÁRMACOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CARVALHO, Jose W. et al. Evaluation of the potential absorbed doses from patients based on whole-body I-131 clearance in thyroid cancer therapy. World Journal of Nuclear Medicine. Viena: Faculdade de Medicina, Universidade de São Paulo. . Acesso em: 02 nov. 2025. , 2006
APA
Carvalho, J. W., Guimarães, M. I. C., Stabin, M. G., Malvestiti, L. F., Sapienza, M., Sordi, G. M. A. A., et al. (2006). Evaluation of the potential absorbed doses from patients based on whole-body I-131 clearance in thyroid cancer therapy. World Journal of Nuclear Medicine. Viena: Faculdade de Medicina, Universidade de São Paulo.
NLM
Carvalho JW, Guimarães MIC, Stabin MG, Malvestiti LF, Sapienza M, Sordi GMAA, Marone MS, Buchpiguel CA. Evaluation of the potential absorbed doses from patients based on whole-body I-131 clearance in thyroid cancer therapy. World Journal of Nuclear Medicine. 2006 ; 5 S48.[citado 2025 nov. 02 ]
Vancouver
Carvalho JW, Guimarães MIC, Stabin MG, Malvestiti LF, Sapienza M, Sordi GMAA, Marone MS, Buchpiguel CA. Evaluation of the potential absorbed doses from patients based on whole-body I-131 clearance in thyroid cancer therapy. World Journal of Nuclear Medicine. 2006 ; 5 S48.[citado 2025 nov. 02 ]
Trabalho de evento-resumo periodico
A new proposal for monitoring patients in nuclear medicine (2006)
Carvalho, J. W. Amorim; Guimarães, Maria Ines C.; Stabin, Michael G.; Malvestiti, Luiz F.; Sapienza, Marcelo; Sordi, Gian Maria A. A.; Marone, Marilia S.; Buchpiguel, Carlos Alberto
Fonte: World Journal of Nuclear Medicine. Nome do evento: Congress of World Federation of Nuclear Medicine & Biology. Unidade: FM
Assuntos: MEDICINA NUCLEAR, DOENÇAS OCUPACIONAIS, RADIOATIVIDADE ARTIFICIAL
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CARVALHO, J. W. Amorim et al. A new proposal for monitoring patients in nuclear medicine. World Journal of Nuclear Medicine. Viena: Faculdade de Medicina, Universidade de São Paulo. . Acesso em: 02 nov. 2025. , 2006
APA
Carvalho, J. W. A., Guimarães, M. I. C., Stabin, M. G., Malvestiti, L. F., Sapienza, M., Sordi, G. M. A. A., et al. (2006). A new proposal for monitoring patients in nuclear medicine. World Journal of Nuclear Medicine. Viena: Faculdade de Medicina, Universidade de São Paulo.
NLM
Carvalho JWA, Guimarães MIC, Stabin MG, Malvestiti LF, Sapienza M, Sordi GMAA, Marone MS, Buchpiguel CA. A new proposal for monitoring patients in nuclear medicine. World Journal of Nuclear Medicine. 2006 ; 5 S66.[citado 2025 nov. 02 ]
Vancouver
Carvalho JWA, Guimarães MIC, Stabin MG, Malvestiti LF, Sapienza M, Sordi GMAA, Marone MS, Buchpiguel CA. A new proposal for monitoring patients in nuclear medicine. World Journal of Nuclear Medicine. 2006 ; 5 S66.[citado 2025 nov. 02 ]

Unidades USP

ReP

Filtros

Autores

Ano de publicação

Assuntos

Indexado em